Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2004 Apr 15;10(8):1218-21.
doi: 10.3748/wjg.v10.i8.1218.

Effects of hemoperfusion adsorption and/or plasma exchange in treatment of severe viral hepatitis: a comparative study

Nian-Hai He  1 , Ying-Jie Wang, Ze-Wen Wang, Jun Liu, Jia-Jia Li, Guo-Dong Liu, Yu-Ming Wang
Affiliations
Clinical Trial

Effects of hemoperfusion adsorption and/or plasma exchange in treatment of severe viral hepatitis: a comparative study

Nian-Hai He et al. World J Gastroenterol. .

Abstract

Aim: Non-bioartificial liver has been applied to clinic for quite a long time, but the reported efficacy has been very different. The aim of this study was to compare the efficacy and safety of hemoperfusion adsorption, plasma exchange and plasma exchange plus hemoperfusion adsorption in treatment of severe viral hepatitis.

Methods: Seventy-five patients with severe viral hepatitis were treated with hemoperfusion adsorption therapy (24 cases), plasma exchange therapy (17 cases) and plasma exchange plus hemoperfusion adsorption therapy (34 cases). The data of liver function, renal function, blood routine test, prothrombin time (PT) and prothrombin activity (PTa) pre- and post-therapy were analyzed.

Results: Clinical symptoms of patients improved after treatment. The levels of aminotransferase, total bilirubin, direct bilirubin decreased significantly after 3 therapies (P<0.05 or P<0.01). PT, the level of total serum protein decreased significantly and PTa increased significantly after plasma exchange therapy and plasma exchange plus hemoperfusion adsorption therapy (P<0.05 or P<0.01). The side effects were few and mild in all patients.

Conclusion: Three therapies were effective in the treatment of severe viral hepatitis. Plasma exchange therapy and plasma exchange plus hemoperfusion adsorption therapy are better than hemoperfusion adsorption therapy.

PubMed Disclaimer

References

    1. Chamuleau RA. Artificial liver support in the third millennium. Artif Cells Blood Substit Immobil Biotechnol. 2003;31:117–126. - PubMed
    1. Chamuleau RA. Bioartificial liver support anno 2001. Metab Brain Dis. 2002;17:485–491. - PubMed
    1. Kjaergard LL, Liu J, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for acute and acute-on-chronic liver failure: a systematic review. JAMA. 2003;289:217–222. - PubMed
    1. Liu J, Kjaergard LL, Als-Nielsen B, Gluud C. Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol. Liver. 2002;22:433–438. - PubMed
    1. He J, Xu TM, Zhou GP, Wang YZ, Pan TJ, Chen GC. [Influence of plasma exchange on serum cytokines in severe viral hepatitis patients] Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003;15:106–108. - PubMed

Publication types